A novel algorithm for lung adenocarcinoma based on <scp>N6</scp> methyladenosine‐related immune long noncoding <scp>RNAs</scp> as a reliable biomarker for predicting survival outcomes and selecting sensitive anti‐tumor therapies-Reference-Cited by-同舟云学术

A novel algorithm for lung adenocarcinoma based on N6 methyladenosine‐related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti‐tumor therapies

Published:2022-08-10 Issue:9 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Yan Qiuwen¹^ORCID,Hu Bingchuan¹,Chen Hang¹,Zhu Linwen¹,Lyu Yao²,Qian Dingding³,Shao Guofeng¹^ORCID

Affiliation:

1. Department of Cardiothoracic Surgery The Affiliated Lihuili Hospital, Ningbo University Ningbo Zhejiang People's Republic of China

2. Department of Pharmacy The Affiliated Lihuili Hospital, Ningbo University Ningbo Zhejiang People's Republic of China

3. Department of Cardiology The Affiliated Lihuili Hospital, Ningbo University Ningbo Zhejiang People's Republic of China

Funder

Natural Science Foundation of Ningbo Municipality

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24636

Reference30 articles.

1. Lung Cancer

2. Cancer statistics, 2022

3. Cancer statistics in China, 2015

4. Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey

5. Traditional Chinese medicine and lung cancer——From theory to practice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer;Biomedicine & Pharmacotherapy;2024-06

2. A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol;2024-04-16

3. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD;Journal of Cellular and Molecular Medicine;2024-04

4. The role of m6A methylation in targeted therapy resistance in lung cancer;American Journal of Cancer Research;2024

5. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer;Frontiers in Pharmacology;2023-02-15